These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18387817)

  • 41. Understanding angiogenesis and its clinical applications.
    Suh DY
    Ann Clin Lab Sci; 2000 Jul; 30(3):227-38. PubMed ID: 10945562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor endothelial cells are targets for selective therapies: in vitro and in vivo models to evaluate antiangiogenic strategies.
    Dutour A; Rigaud M
    Anticancer Res; 2005; 25(6B):3799-807. PubMed ID: 16309166
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiogenesis--a new target for future therapy.
    Pandya NM; Dhalla NS; Santani DD
    Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic targeting of the tumor vasculature.
    Tozer GM; Bicknell R
    Semin Radiat Oncol; 2004 Jul; 14(3):222-32. PubMed ID: 15254865
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiangiogenic effect of licochalcone A.
    Kim YH; Shin EK; Kim DH; Lee HH; Park JH; Kim JK
    Biochem Pharmacol; 2010 Oct; 80(8):1152-9. PubMed ID: 20637733
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises.
    Van Langendonckt A; Donnez J; Defrère S; Dunselman GA; Groothuis PG
    Mol Hum Reprod; 2008 May; 14(5):259-68. PubMed ID: 18430758
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antioxidant and antiangiogenic properties of phenolic extract from Pleurotus tuber-regium.
    Lin S; Lai Tc; Chen L; Kwok Hf; Lau CB; Cheung PC
    J Agric Food Chem; 2014 Oct; 62(39):9488-98. PubMed ID: 25185869
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumour angiogenesis pathways: related clinical issues and implications for nuclear medicine imaging.
    Van De Wiele C; Oltenfreiter R; De Winter O; Signore A; Slegers G; Dierckx RA
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):699-709. PubMed ID: 11976811
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New insights into the antiangiogenic and proangiogenic properties of dietary polyphenols.
    Diniz C; Suliburska J; Ferreira IMPLVO
    Mol Nutr Food Res; 2017 Jun; 61(6):. PubMed ID: 27981783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Flavonoid-Based Cancer Therapy: An Updated Review.
    Hosseinzadeh E; Hassanzadeh A; Marofi F; Alivand MR; Solali S
    Anticancer Agents Med Chem; 2020; 20(12):1398-1414. PubMed ID: 32324520
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Flavonoids with Anti-Angiogenesis Function in Cancer.
    Wei Q; Zhang YH
    Molecules; 2024 Mar; 29(7):. PubMed ID: 38611849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A review of molecular mechanisms involved in anticancer and antiangiogenic effects of natural polyphenolic compounds.
    Abbaszadeh H; Keikhaei B; Mottaghi S
    Phytother Res; 2019 Aug; 33(8):2002-2014. PubMed ID: 31373113
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiosuppressive properties of marine-derived compounds-a mini review.
    Yue PY; Leung HM; Li AJ; Chan TN; Lum TS; Chung YL; Sung YH; Wong MH; Leung KS; Zeng EY
    Environ Sci Pollut Res Int; 2017 Apr; 24(10):8990-9001. PubMed ID: 26520098
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Flavonoids as Multi-Target Compounds: A Special Emphasis on their Potential as Chemo-adjuvants in Cancer Therapy.
    Namdeo AG; Boddu SHS; Amawi H; Ashby CR; Tukaramrao DB; Trivedi P; Babu RJ; Tiwari AK
    Curr Pharm Des; 2020; 26(15):1712-1728. PubMed ID: 32003663
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optical properties and antiangiogenic activity of a chalcone derivate.
    Lemes SR; Júnior LA; da Silva Manoel D; de Sousa MAM; Fonseca RD; Lima RS; Noda-Perez C; de Melo Reis PR; Cardoso CG; de Paula Silveira-Lacerda E; Souza MAR; Mendonça CR; Gonçalves PJ; de Boni L; da Fonseca TL; da Silva Junior NJ
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Nov; 204():685-695. PubMed ID: 29982160
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Review on Dietary Flavonoids as Modulators of the Tumor Microenvironment.
    Duan N; Hu X; Zhou R; Li Y; Wu W; Liu N
    Mol Nutr Food Res; 2023 Apr; 67(7):e2200435. PubMed ID: 36698331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Shark cartilage as source of antiangiogenic compounds: from basic to clinical research.
    González RP; Leyva A; Moraes MO
    Biol Pharm Bull; 2001 Oct; 24(10):1097-101. PubMed ID: 11642310
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioavailability of chalcones.
    Hijova E
    Bratisl Lek Listy; 2006; 107(3):80-4. PubMed ID: 16796129
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence.
    Salehi B; Quispe C; Chamkhi I; El Omari N; Balahbib A; Sharifi-Rad J; Bouyahya A; Akram M; Iqbal M; Docea AO; Caruntu C; Leyva-Gómez G; Dey A; Martorell M; Calina D; López V; Les F
    Front Pharmacol; 2020; 11():592654. PubMed ID: 33536909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.